Table 2 Primary and secondary outcome at 3 months
Variables | Intervention group (n = 14) | Control group (n = 22) | Between-group difference (p valuea) |
|---|---|---|---|
Primary outcome | |||
ACR (mg/gCr) | |||
Baseline | 706.1 ± 1081.2 | 212.5 ± 322.5 | |
After 3 months | 440.0 ± 656.3 | 163.5 ± 161.5 | |
Change | -266.1 ± 436.3 | -49.0 ± 261.2 | 0.070 |
Within-group difference (p valueb) | 0.040 | 0.388 | |
Secondary outcome | |||
Systolic blood pressure (mmHg) | |||
Baseline | 145.1 ± 13.9 | 134.9 ± 13.1 | |
After 3 months | 130.9 ± 12.9 | 130.9 ± 14.0 | |
Change | -14.3 ± 13.9 | -4.0 ± 14.6 | 0.043 |
Within-group difference (p valueb) | 0.002 | 0.212 | |
Diastolic blood pressure (mmHg) | |||
Baseline | 67.1 ± 8.3 | 66.4 ± 12.2 | |
After 3 months | 62.7 ± 7.6 | 66.8 ± 7.8 | |
Change | -4.4 ± 7.6 | 0.5 ± 11.3 | 0.165 |
Within-group difference (p valueb) | 0.048 | 0.853 |